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Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is an illicit psychoactive
drug that has gained immense popularity among teenagers and young adults.
The cardiovascular toxicological consequences of abusing this compound
have not been fully characterized. The present study utilized a transient transfec-
tion/dual luciferase genetic reporter assay, fluorescence confocal microscopy,
and gene expression macroarray technology to determine nuclear factor-B
(NF-B) activity, intracellular calcium balance, mitochondrial depolarization,
and gene transcription profiles, respectively, in cultured rat striated cardiac
myocytes (H9c2) exposed to MDMA. At concentrations of 1  103 M and
1  102 M, MDMA significantly enhanced NF-B reporter activity compared
with 0 M (medium only) control. This response was mitigated by cotransfec-
tion with IB for 1  103 M but not 1  102 M MDMA. MDMA significantly
increased intracellular calcium at concentrations of 1  103 M and 1  102
M and caused mitochondrial depolarization at 1  102 M. MDMA increased
the transcription of genes that are considered to be biomarkers in cardiovas-
cular disease and genes that respond to toxic insults. Selected gene activation
was verified via temperature-gradient RT-PCR conducted with annealing tem-
peratures ranging from 50°C to 65°C. Collectively, these results suggest that
MDMA may be toxic to the heart through its ability to activate the myocardial
NF-B response, disrupt cytosolic calcium and mitochondrial homeostasis,
and alter gene transcription.
Key Words: MDMA; NF-B; nuclear factor; H9c2; cardiac myocytes; calcium.
Introduction
3,4-Methylenedioxymethamphetamine (MDMA) is an illicit psychoactive drug
taken for its mood-altering and stimulating effects. This drug shares structural homol-
ogy with amphetamine and mescaline, which helps explain its hybridized pharmaco-
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logical properties (1). MDMA is a particular favorite
among teens and young adults at all-night dance par-
ties called “raves” and often goes by the street name
“ecstasy.” Although considered safe by many users,
studies have shown that MDMA may in fact be detri-
mental to multiple organ systems including the car-
diovascular system (1–3).
In human subjects, MDMA use is associated with
abnormal increases in heart rate, mean arterial pres-
sure, and myocardial wall stress (2). In rats, binge pat-
tern intravenous administration of MDMA (9 mg/kg)
can cause profound and progressive bradycardia with
accompanying hypotension (3). Autonomic dysreg-
ulation is suspected to contribute to the rhythmic and
pressor abnormalities seen with MDMA abuse and
may involve increased net release of norepinephrine
and -adrenergic receptor interaction (1,4,5). In addi-
tion, elevated intracellular calcium, as seen with other
stimulants such as cocaine, may lead to further com-
plications including myocardial hypertrophy, fibro-
sis, and apoptosis (6).
The mechanism(s) by which MDMA causes ad-
verse cardiovascular effects remains unclear. One
transcription factor that may be activated by MDMA
is nuclear factor- B (NF-B). NF-B is a ubiquitous
protein transcription factor found in a wide variety
of cell types as a heterodimer consisting of p50 and
p65 subunits (7–10). Under basal conditions, NF-B
is localized mainly in the cytoplasm, where it is toni-
cally inhibited by reversible binding to an inhibitory
(I-B) family of regulatory proteins (11). Activation
occurs when B becomes phosphorylated and sub-
sequently degraded, allowing for translocation of
the heterodimer to the nucleus, where NF-B binds
to B-response elements in the promoter/enhancer
regions of various genes (7,12–17). This process up-
regulates the expression of inflammatory cytokines,
chemotactic proteins, and cellular adhesion mole-
cules (17). Several known inducers of NF-B include
interleukin 1 (IL)- IL-6, IL-8, tumor necrosis factor
(TNF)-, lipopolysaccharide, physical trauma, ion-
izing radiation, and free radicals (18–22).
In the heart, there is evidence that NF-B is pro-
inflammatory as well as antiapoptotic. Cultured car-
diac myocytes exposed to hydrogen peroxide show
an increased activation of NF-B (23). Myocardial
intercellular adhesion molecule-1 and vascular cell
adhesion molecule-1 (VCAM-1) gene expression are
effectively reduced in the presence of NF-B inhibi-
tors (24,25). These cell surface proteins are impor-
tant in mediating inflammatory cell recruitment and
infiltration by acting as counter-receptors for circu-
lating monocyte and lymphocyte integrins (25). The
antiapoptotic nature of NF-B has been demonstrated
in primary cultures of rat ventricular myocytes. In
these cells, TNF--induced apoptosis is significantly
enhanced on NF-B inhibition (26).
Currently, there is very little information in the lit-
erature concerning the direct effects of MDMA on
NF-B regulation and on intracellular calcium home-
ostasis. One recent study showed that MDMA simul-
taneously increased reactine oxygen species (ROS)
production and depleted reduced glutathione levels
in hepatic stellate cells (27). Other investigators have
shown that MDMA increases hydroxyl radical for-
mation in the rat brain (28). Theoretically, the oxida-
tive environments imposed by MDMA administra-
tion in these studies represent ideal conditions for
NF-B activation and subsequent upregulation of the
inflammatory response. There is already evidence that
links MDMA exposure to increased lymphocyte infil-
tration and inflammatory damage to the myocardium
(myocarditis) (3). However, the degree of NF-B in-
volvement with this response remains unknown. From
the current available evidence, it is our hypothesis
that MDMA may activate NF-B in cultured striated
heart cells and alter calcium homeostasis. We hypoth-
esize that MDMA can abnormally increase intracel-
lular calcium and modulate the expression of genes
important to the myocardial pathological and toxico-
logical response.
Materials and Methods
Cell Culture and Maintenance
Cultured rat striated cardiac myocytes (H9c2) from
the rat (Rattus norvegicus) were purchased from
American Type Culture Collection (ATCC; Beth-
esda, MD) and cultured in a T-75 flask at 37°C and 5%
atmospheric CO2 (incubator controlled). The culture
medium consisted of 15 mL Dulbecco’s Modified
Eagle’s Medium (ATCC) containing 10% fetal bovine
serum (FBS). With the aid of a hemacytometer, approx
150,000 resuspended cells were plated onto each well
of a sterile 12-well culture plate and returned to the
incubator for 24 h.
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Measurement of Luciferase Activity
The transfection procedure was performed over a
4-d period as previously described (29). Briefly, on
d 1 of the protocol, approx 150,000 cells were plated
onto each well of a 12-well culture plate and returned
to the incubator for 24 h. On d 2, the cells were trans-
fected by the FuGENE™ (Roche, Nutley, NJ) method
with 1.0 g of a plasmid containing firefly luciferase
DNA coupled to the NF-B promoter, and 0.1 g of
a second plasmid with Renilla luciferase DNA cou-
pled to the constitutively active SV40 promoter (in-
ternal control). In a separate set of experiments, 1.0
g IB DNA was transfected to determine the drug
concentration at which NF-B activation could be
blocked. As described in a previous study, IB expres-
sion was driven by the cyto-megalo virus CMV pro-
moter from the plasmid pCMV-IB  (also known as
pCMV-RLIF) (30). On d 3, the cells were stimulated
with MDMA; the concentrations used were 1  106
M, 1  105 M, 1  104 M, 1  103 M, and 1  102 M.
MDMA was dissolved in 2 mL of cell culture medium
and gently added to each well in duplicates. Cell
culture medium alone (without drug) was added to
cells that served as our controls (0 M). The cells were
returned to the incubator for 24 h. On d 4, the cells
were lysed and the lysate was analyzed for firefly
and Renilla luciferase activities using a dual-injec-
tor luminometer. A dual-luciferase method was used
in order to control for possible differences in trans-
fection efficiency and cell viability between indepen-
dently treated culture wells. The ratio of experimen-
tal signal to internal control signal was determined.
Intracellular Calcium and Mitochondrial
Depolarization Measurements
Several classes of pharmacological agents were
utilized alone or in combination to determine changes
in cytosolic calcium. To assess changes in intracel-
lular and mitochondrial calcium, we used rhod-2 and
fluo-3. The mitochondrial potentiometric indicator
JC-1 was used to determine mitochondrial depolar-
ization. Fluorescent indicators fluo-3 AM, rhod-2
AM, and JC-1 were obtained from Molecular Probes
(Eugene, OR) and dissolved in dry dimethyl sulfox-
ide (DMSO) at stock solutions that permitted a 1:1000
dilution to achieve the final loading concentrations
of 5 M, 5 M, and 2 g/mL, respectively. For some
experiments, rhod-2 AM in DMSO was reduced with
sodium borohydride to permit a more specific load-
ing of the reduced indicator into mitochondria (31).
Loading buffer comprised Hank’s Modified Eagle’s
Medium without FBS or phenol red, but with 0.01%
pluronic 127 for the calcium and ROS indicators.
The pluronic 127 was added before the addition of
the indicator(s). The loading medium was then soni-
cated for 2 min before the cells were washed and load-
ing medium added. The cells were incubated in the
presence of the indicators for 30–60 min at 37°C in
95%air/5%CO2. Cells were then washed to remove
excess indicator and then maintained at 25°C for the
remainder of the experiment.
Measurements were taken in the multiwell plates
using a custom holder in a Zeiss 510 laser confocal
microscope with Meta attachments (Zeiss, Jena, Ger-
many). All measurements were made using a Zeiss
10X Plan Neofluar objective. The frame size was
512  512 pixels with 1024-byte resolution. Nomi-
nal optical section thickness was 2 m with voxel
size equal to 6.5 m3 and approx 15–30 optical sec-
tions were obtained. The emission filters were a Zeiss
560 LP (long pass) used for rhod-2 and a Zeiss BP
(band pass) 505-550 for fluo-3. The primary dichroic
was a Zeiss HFT 488/543 to separate the 488 and 543
laser lines and reflect the 543 wavelength to a Zeiss
NFT 545 dichroic placed in front of the LP560 filter.
The pinhole sizes used were set to a nominal 1.0 Airy
units, which for the 10 objective was 80 and 76 m
for the red and green channels, respectively. Laser
settings were adjusted to achieve minimal photo-
bleaching or photo-activation. Control measurements
indicated no significant increase or decrease of indi-
cator intensity during the entire protocol. Background
subtraction was taken from indicator loaded/nonstim-
ulated cells, while a saturated signal for internal nor-
malization was obtained by introducing the calcium
ionophore ionomycin.
The generic protocol included obtaining a control
measurement, removing Hank’s buffer with selected
pretreatment agents, and then adding buffer with
or without cocaine hydrochloride (Sigma, St. Louis,
MO) at 105 to 102 M along with any pretreatment
agents. Measurements were made at 2 and 5 min post-
addition, followed by 2- and 5-min measurements
after the addition of 10–50 M ionomycin or A23187
(Sigma) to elevate intracellular calcium activity or
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50 M carbonyl cyanide m-chlorophenyl hydrazone
(CCCP; Sigma) to uncouple mitochondria during JC-
1 experiments. Kds of 390 and 570 nM (determined at
22C in 0.1 M KCl, pH 7.1, by manufacturer) were
used to estimate intracellular calcium activities for
fluo-3 and rhod-2, respectively. To permit compari-
son of mitochondrial membrane depolarization, we
calculated the ratio of the red (polarized = P)/green
(depolarized = D) JC-1 signals, correcting for their
respective background fluorescence. Thus Ratio = (P-
red background/D-green background). The change in
mitochondrial fluorescence was expressed as per-
cent change from the difference of the untreated, con-
trol cell ratio and the CCCP treated, depolarized cell
ratio for that well. Three separate wells for each expe-
rimental manipulation were analyzed on different days
for each experimental condition.
Analysis of Gene Expression
by Macarray and RT-PCR
H9c2 cells in six flasks, each approx 85% confluent,
were equally and randomly divided into two groups:
0 M MDMA (no MDMA in medium) and 1  103 M
MDMA dissolved in medium. The cell medium was
removed and discarded. Ten milliliters of the drug
solution was made fresh and added to each flask ac-
cording to its treatment group: 0 M MDMA (medium
only), or 1  103 M MDMA in medium. After 24 h of
stimulation, the drug solution was removed and dis-
carded. Adherent cells were loosened by exposing
the cell monolayer to 2 mL of 0.25% trypsin EDTA.
After 2 min trypsin was removed and discarded. The
cells were then resuspended in 10 mL of fresh medium
and centrifuged at 5000g for 10 min at 4C. The super-
natant was removed and discarded. Cell pellets were
gently washed with 1 mL phosphate buffered saline
(PBS) and centrifuged in a new RNase-free mini-cen-
trifuge tube at 12,000g for 4 min at room tempera-
ture. The PBS was removed and discarded.
The Trizol method was used to extract total RNA
(GibcoBRL, Grand Island, NY). Trizol (0.3 mL) was
added to each tube and the contents were mixed by
inversion for 2 min. Chloroform (0.1 mL) was added
to each tube and the contents mixed by shaking for
15 s. All tubes were incubated for 2 min at room tem-
perature. The tubes were then centrifuged at 12,000g
for 10 min. The supernatant (containing RNA) was
carefully removed and placed into new RNase-free
mini-centrifuge tubes. An equal volume of 100% iso-
propanol was added to precipitate the RNA. After
centrifugation at 12,000g for 10 min, the supernatant
was removed and discarded. The RNA pellet was
resuspended in 70% ethanol (made in diethyl pyro-
carbonate [DEPC] water) and centrifuged again at
12,000g for 5 min, after which the supernatant was
removed and discarded. The RNA pellet was air dried
and then reconstituted with DEPC water.
cDNA was made from total RNA using a probe
synthesis kit obtained from SuperArray. After pre-
hybridization with denatured sheared salmon sperm
DNA (100 g/mL), the probe was added to the hy-
bridization tubes and incubated for 48 h at 60°C with
continuous agitation at 7280g. For chemilumines-
cent detection, the membrane was washed, blocked,
and then incubated with alkaline phosphatase-con-
jugated streptavidin (1:7,500 dilution) for 10 min at
room temperature with gentle agitation. The mem-
branes were exposed to substrate and then placed into
sealed plastic bags for imaging. The membranes
were photographed using a VersaDoc digital imag-
ing system (Bio-Rad, Hercules, CA) with a compu-
ter program interface to quantify chemiluminescent
signals for each spot on the array (Quantity One).
GEArray™ Q Series Kits from SuperArray (Frederick,
MD) were used to assess gene activation or repression.
One array contained genes important to cardiovascu-
lar pathology (Mouse Cardiovascular Disease I: Bio-
markers). The other array contained genes important
to cardiovascular toxicology (Mouse Stress & Tox-
icity Pathway Finder). Each membrane for a given
macroarray contained 96 genes.
To verify the results obtained from the macroarray
experiments, we performed gene-specific RT-PCR
utilizing kits obtained from SuperArray. cDNA was
made from the total RNA isolated in the array expe-
riment. A temperature-gradient PCR was conducted
with annealing temperatures ranging from 50C to
65C. The PCR products were subjected to electro-
phoresis on 2% agarose containing GelStar (Cambrex
Bio Science, Rockland, ME). The gels were imaged
under a UV illuminator and analyzed by densitom-
etry. Because of the number of genes contained in the
macroarray, we necessarily had to restrict confirma-
tion to a few candidates. Change in expression levels
seen with troponin I,VCAM-1, and proliferating cell
nuclear antigen (PCNA) were confirmed by RT-PCR.
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Data Analysis
For luciferase activity, duplicate wells were aver-
aged for three separate studies, and single-factor
ANOVA followed by multiple comparison testing was
performed on the mean values. For the gene expres-
sion array, raw signals were analyzed using GEArray
Analyzer software available for download at the Super
Array website (www.superarray.com). Background
was subtracted from the blank on the membrane and
normalized to the housekeeping gene for glyceral-
dehyde-3-phosphate dehydrogenase. According to
SuperArray instructions, genes with a signal ratio
>2.0 (experimental array/control array) and those
with signal ratios >1.0 with raw intensities >10% of
the housekeeping gene were considered upregulated.
Genes with a ratio <0.5 were considered downreg-
ulated. Activation of three genes was verified with
RT-PCR. When assessing changes in intracellular
calcium, we collected the average intensity measure-
ments for 20 cells per field at each optical section,
using areas of 60–100 pixels within the respective
cell. Data files were collected in Metamorph, and
then transferred to an Excel spreadsheet for subse-
quent statistical analysis by paired t-test. All data are
stated as the mean 	 standard deviation unless other-
wise indicated.
Results
NF-B Genetic Reporter Experiments
These experiments were performed to determine
the effect of MDMA on NF-B activation in cultured
cardiac myocytes. In cultured H9c2 cells, MDMA
significantly activated NF-B at concentrations of
1  103 M and 1  102 M. However, the drug was
unable to cause activation at the lower concentrations
tested. This indicates that MDMA activates NF-B
in cultured H9c2 cells in a dose-dependent manner.
Also, cotransfection of IB significantly reduced
NF-B activity caused by 1  103 M MDMA, but
not by 1  102 M MDMA (Fig. 1).
Confocal Microscopy Experiments
To determine if MDMA increased intracellular
calcium levels and/or caused mitochondrial depo-
larization in H9c2 cells, we performed quantitative
confocal microscopy using standard fluorescent cal-
cium indicators and the potentiometric JC-1 indica-
tor, respectively. Figure 2 shows a significant increase
in intracellular calcium 2 and 5 min after MDMA
exposure. Figure 3A (cells stimulated with medium
only and serving as controls) and 3B (cells stimulated
with 1  102 M MDMA) show a representative ex-
Fig. 1. Nuclear factor-kB reporter activity in H9c2 cells exposed to 3,4-methylenedioxymethamphetamine (MDMA;
n = 3) for 24 h. Cells in wells that were not exposed to MDMA (0 M drug) received medium only and served as controls.
Experiments involving IkB were performed independently. Data are expressed as a ratio (experimental signal/internal
control signal) of mean relative luminometry units (RLU) ± SD (*p > 0.05).
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ample of cells incubated with the fluorescent calcium
indicator fluo-3 and stimulated acutely with and
without MDMA. These results suggest that MDMA
can increase intracellular calcium in a concentration-
and time-dependent manner.
Figure 4 A (cells stimulated with medium only and
serving as controls) and 4B (cells stimulated with
MDMA 1  102 M) show a representative example of
H9c2 cells pretreated with the mitochondrial-speci-
fic potentiometric indicator JC-1 and stimulated with
or without MDMA. MDMA caused depolarization
of mitochondrial membranes, suggesting that this
drug is detrimental to energy homeostasis in cardiac
myocytes.
Gene Analysis Experiments
These experiments were performed after the lumi-
nometry experiments revealed the minimally effec-
Fig. 2. Changes in intracellular calcium in H9c2 cells 2 and 5 min after exposure to 3,4-methylenedioxymetham-
phetamine (MDMA). The cells were incubated in the presence of the indicator for 30–60 min at 37°C in 95% air/5% CO
2
and then stimulated with MDMA. Data are stated as percent of control. * indicates p < 0.01.
Fig. 3. (A) A representative example of H9c2 cells loaded with the calcium indicator Fluo 3 and stimulated acutely with
medium only (control). The cells were incubated in the presence of the indicator for 30–60 min at 37°C in 95% air/5%
CO
2 
and then stimulated with 3,4-methylenedioxymethamphetamine (MDMA). (B) A representative example of H9c2
cells loaded with the calcium indicator Fluo 3 and stimulated acutely with MDMA 1  102 M. Each well served as its
own control. The measure bar is 90 mm.
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tive concentration of MDMA required to cause NF-
B activation in cultured H9c2 cells and to deter-
mine if MDMA activated the transcription of genes
known to be associated with cardiovascular disease
and stress toxicology. Exposure of H9c2 cells to 1 
103 M MDMA for 24 h activated multiple genes that
are considered to be biomarkers for cardiovascular
disease and genes that are activated in response to
toxicity and stress. The genes activated by a factor

2.0 or 0.5 are reported in Table 1. Note that these
values are derived from a single experimental deter-
mination and heterologous hybridization (rat on
mouse). Activation of the troponin gene (Fig. 5),
VCAM-1, and PCNA genes (Table 2) were verified
with RT-PCR.
Discussion
MDMA is an extremely popular illicit drug with
chronic abuse potential. The direct effects of MDMA
on cardiac myocytes have not been fully characterized.
In this study, we observed that MDMA (1  103 M
and 1  102 M) significantly activates transcription
factor NF-B in cultured H9c2 cells in a dose-depen-
dent manner. Previous investigators have associated
Fig. 4. (A) A representative example of H9c2 cells loaded with the mitochondrial indicator JC-1 and stimulated
acutely with medium only (control). The cells were incubated in the presence of the indicator for 30–60 min at 37°C in
95% air/5% CO
2 
and then stimulated with 3,4-methylenedioxymethamphetamine (MDMA). (B) A representative exam-
ple of H9c2 cells loaded with the mitochondrial indicator JC-1 and stimulated acutely with MDMA 1  102 M. Each well
served as its own control. The measure bar is 90 mm.
the abuse of MDMA with increased lymphocyte infil-
tration and inflammatory damage to the myocardium
(3). Our current findings support a possible mechanism
for this to occur. MDMA exposure activates NF-B,
which in turn upregulates the expression of cytokines
and cellular adhesion molecules that are important
to the myocardial inflammatory response. This con-
cept is supported by the fact that we observed the
upregulation of genes associated with inflammation
(Table 1A).
MDMA increased the transcription of the Cox-2
gene. This gene encodes for an enzyme known to
be localized within regions of myocardial inflamma-
tion and fibrotic scar formation, especially in patients
with congestive heart failure (32). The upregulation
of the Scya2 and MIP-1b genes (Table 1A,B) sug-
gests that these chemotactic proteins may promote
leukocyte migration to the myocardium. The adhesion
molecule gene VCAM-1 was strongly upregulated,
displaying a notable 12-fold increase over control,
the upregulation of which was verified by RT-PCR.
VCAM-1 may be involved with leukocyte binding to
the myocardium. This particular gene is specifically
regulated by NF-B, corroborating the increased activ-
ity of NF-B observed in our genetic reporter studies.
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The activity of two genes associated with myocar-
dial remodeling and hypertrophy was also affected by
MDMA. Gelatinase A, which encodes for a matrix-de-
grading enzyme, and its inhibitor (Timp) were down-
regulated. This suggests that MDMA may not alter
the extracellular matrix. However, the increased tran-
scription of growth-promoting genes such as cyclin
D1, cyclin G, and PCNA suggests that MDMA may
be prohypertrophic. The ability of MDMA to activate
growth-related genes may act in synergy with its sys-
temic ability to enhance the release of norepineph-
rine, a stimulator of hypertrophic growth in the chron-
ically affected myocardium.
Several other key genes were activated in the pres-
ence of MDMA including heat shock proteins B-
crystallin (cryab), mortalin-2 (PBP-74), HSP25, HSP
60, and HSP4. These prosurvival genes are normally
induced by chemical, hyperosmotic, and ischemic
insults. In addition, the upregulation of DNA-repair
factors Gadd45 and RAD23A suggests that MDMA
may also have genotoxic properties. The activation
of these genes by MDMA suggests that the cells are
Fig. 5. A representative example of an agarose gel using
temperature-gradient PCR conducted with annealing tem-
peratures ranging from 50°C to 65°C. The PCR product
troponin 1 was subjected to electrophoresis on 2% agarose
containing GelStar. The gel was imaged under a UV illu-
minator and analyzed by densitometry. The arrow indi-
cates an annealing temperature of 59°C for H9c2 cells stim-
ulated with medium only (control) and H9c2 cells treated





























(A) Genes in the cardiovascular disease macroarray activated/
repressed by 3,4-methylenedioxymethamphetamine (MDMA):
apolipoprotein-2 (Apoc2), chemokine ligand 2 (Scya2), plas-
minogen activator urokinase receptor (PLAUR), tissue inhibi-
tor of metalloproteases (Timp), troponin 1, vascular cell adhesion
molecule 1 (VCAM-1). (B) Genes in the stress/toxicity macro-
array activated/repressed by MDMA: crystallin, a B (cryab),
growth arrest and DNA damage inducible protein 45 (Gadd45),
heat shock protein 60 (Hsp60), heart shock protein 4 (Hspa4),
peptide binding protein 74 (PBP74), proliferating cell nuclear
antigen (PCNA), cyclooxygenase-2 (Cox 2), chemokine ligand
4 (MIP-1b), fas ligand (FasL), tumor protein p53 (p53). The
gene is listed as activated if the ratio of treated to control was 2.0
or greater or if the raw number indicating activity of the treated
cells was 10% of the housekeeping gene (GAPDH = 1.00). The
gene is listed as repressed if the ratio of treated to control was
0.5 or less. Ratios are expressed as relative densitometry values
(experimental/control).
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stressed in some manner by the drug and that a cellu-
lar compensatory response is initiated to counteract
exposure and promote survival. Furthermore, MDMA
appeared to repress the proapoptotic genes caspase-1,
caspase-8, and FasL, suggesting that under our expe-
rimental conditions, the adverse effects associated
with MDMA may not be caused by activation of the
apoptotic mechanism.
Genetic arrays provide the advantage of observing
the activity of several genes simultaneously at the
level of transcription. An obvious limitation is that
posttranscriptional events may also influence the ulti-
mate expression of a gene in question and this cannot
be determined with the present methodology. Never-
theless, alterations in gene transcription are compell-
ing first evidence that MDMA affects the cardiovas-
cular system at the cellular level.
MDMA caused a significant increase in concen-
tration of intracellular calcium in the H9c2 cells and
this may have important implications for the intact
heart. Disruptions in calcium homeostasis may abnor-
mally alter myocardial excitability and contractility
and induce arrhythmia or ventricular fibrillation. In-
creased intracellular calcium may also affect signal-
ing pathways, leading to diverse responses including
fibrosis and hypertrophy. In addition, calcium over-
load is also known to induce apoptosis via calcineu-
rin-mediated dephosphorylation of Bcl 2-antagonist
of cell death (BAD) and subsequent migration of
BAD to the mitochondria, where it initiates caspase
activation (33). Whereas our findings did not show
activation of caspase-1 and caspase-8 transcription,
we did see mitochondrial depolarization in response
to MDMA. Therefore, the net effect of MDMA-in-
duced calcium overload on cardiac myocytes may be
promotion of hypertrophic growth and mitochon-
drial damage.
In conclusion, this study provides evidence in sup-
port of the hypothesis that MDMA exposure, at cer-
tain concentrations, may be toxic to the myocardium.
Acute intracellular calcium overload constitutes an
immediate/early consequence of abusing this drug,
which may contribute to cardiac rhythmic abnormal-
ities. NF-B activation and perturbations in gene ex-
pression may lead to chronic sequelae, as it is likely
that this compound may prove to be increasingly detri-
mental to the heart in long-term abusers.
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